RENOVARO INC. - COMMON STOCK

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

07 Jan 2025 08:15:00 By Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

07 Jan 2025 08:15:00 By Nasdaq GlobeNewswire

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

06 Jan 2025 08:15:00 By Nasdaq GlobeNewswire

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

30 Dec 2024 08:00:05 By Nasdaq GlobeNewswire

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

23 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Renovaro Regains Compliance with NASDAQ Listing Requirement

20 Dec 2024 14:40:00 By Nasdaq GlobeNewswire

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

20 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

04 Nov 2024 07:31:00 By Nasdaq GlobeNewswire

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17 Oct 2024 08:15:17 By Nasdaq GlobeNewswire

Renovaro Announces Strategic Restructuring and Leadership Transition

16 Oct 2024 08:28:06 By Nasdaq GlobeNewswire

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

19 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

17 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

13 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

11 Sep 2024 08:15:00 By Nasdaq GlobeNewswire

Renovaro, Inc. Announces $10 million in Equity Committed

14 Jun 2024 08:06:00 By Nasdaq GlobeNewswire

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

24 May 2024 08:20:00 By Nasdaq GlobeNewswire

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

30 Apr 2024 10:00:00 By Nasdaq GlobeNewswire

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

24 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care

18 Apr 2024 07:45:00 By Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

15 Feb 2024 08:25:00 By Nasdaq GlobeNewswire